800 billion won in diagnostic kit sales… Article 1 New Club Membership
KOSDAQ listed company Seegene (096530)It recorded the highest performance since its inception last year. This is thanks to the sales of about 800 billion won worth of diagnostic kits for novel coronavirus infection (Corona 19) worldwide.
On the 18th, Seegene announced that it achieved sales of 1.125.2 trillion won and operating profit of 676.2 billion won last year. Compared to 2019, sales increased by about 9 times and operating profit by nearly 30 times. Based on operating profit Samsung Biologics (207940)According to stock prices such as F&Guide, which is more than twice the amount of KRW 292.8 billion recorded by Celltrion (068270)This is expected to be almost unique. Net profit increased by 1,783.8% to 5031 billion won.
Seegene rewritten its record-high performance every quarter last year. According to Shinhan Investment Corp., sales of the Corona 19 diagnostic kit are expected to reach 824.3 billion won last year. Sales of other respiratory products and sexually transmitted diseases also increased significantly.
Seegene is preparing for the post-Covid-19 virus by developing diagnostic products that can check whether the virus is infected with the Corona 19 mutation in South Africa and the UK. Some forecast that the demand for diagnostic kits will decrease as the corona19 vaccination begins, but as the installation of Seegene’s diagnostic devices that can confirm infection has been steadily increasing to date, it is believed that mid- to long-term customers have been secured regardless of whether the corona19 ends in the future. see.
/ Reporter Ji-hye Seo [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >